Barinthus Biotherapeutics Plc logo

Barinthus Biotherapeutics Plc share price today

(BRNS)

Barinthus Biotherapeutics Plc share price is $1.11 & ₹94.57 as on 25 Dec 2024, 2.30 'hrs' IST

$1.11

-0.05

(-4.31%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Barinthus Biotherapeutics Plc share price in Dollar and Rupees. Guide to invest in Barinthus Biotherapeutics Plc from India. Also see the sentimental analysis on Indian investors investing in Barinthus Biotherapeutics Plc. Get details on the Indian mutual funds that are investing in Barinthus Biotherapeutics Plc. Get Analyst recommendations and forecasts along with all the Barinthus Biotherapeutics Plc's financials.

Barinthus Biotherapeutics Plc share price movements

  • Today's Low: $1.07
    Today's High: $1.17

    Day's Volatility :8.25%

  • 52 Weeks Low: $0.80
    52 Weeks High: $4.16

    52 Weeks Volatility :80.75%

Barinthus Biotherapeutics Plc Returns

PeriodBarinthus Biotherapeutics PlcIndex (Russel 2000)
3 Months
-7.5%
0.0%
6 Months
-19.86%
0.0%
1 Year
-69.35%
0.0%
3 Years
-88.92%
-21.1%

Barinthus Biotherapeutics Plc Key Statistics

in dollars & INR

Previous Close
$1.16
Open
$1.07
Today's High
$1.1661
Today's Low
$1.0699
Market Capitalization
$44.7M
Today's Volume
$29.0K
52 Week High
$4.1591
52 Week Low
$0.8008
Revenue TTM
$15.0M
EBITDA
$-59.8M
Earnings Per Share (EPS)
$-1.49
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-32.6%

How to invest in Barinthus Biotherapeutics Plc from India?

It is very easy for Indian residents to invest directly in Barinthus Biotherapeutics Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Barinthus Biotherapeutics Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Barinthus Biotherapeutics Plc or BRNS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Barinthus Biotherapeutics Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Barinthus Biotherapeutics Plc shares which would translate to 0.768 fractional shares of Barinthus Biotherapeutics Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Barinthus Biotherapeutics Plc, in just a few clicks!

Returns in Barinthus Biotherapeutics Plc for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Barinthus Biotherapeutics Plc investment value today

Current value as on today

₹32,902

Returns

₹67,098

(-67.1%)

Returns from Barinthus Biotherapeutics Plc Stock

₹69,337 (-69.34%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Barinthus Biotherapeutics Plc

360%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Barinthus Biotherapeutics Plc on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 360% more investors are searching Barinthus Biotherapeutics Plc in the last 30 days versus the previous period.

Global Institutional Holdings in Barinthus Biotherapeutics Plc

  • M&G PLC

    12.92%

  • Alphabet Inc

    3.76%

  • SC China Holding Ltd

    3.53%

  • DC Funds, LP

    1.60%

  • BlueCrest Capital Management Ltd.

    1.35%

  • The Johns Hopkins University

    0.30%

Analyst Recommendation on Barinthus Biotherapeutics Plc

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Barinthus Biotherapeutics Plc(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Barinthus Biotherapeutics Plc

What analysts predicted

Upside of 553.15%

Current:

$1.11

Target:

$7.25

Insights on Barinthus Biotherapeutics Plc

  • Price Movement

    In the last 7 days, BRNS stock has moved up by 8.8%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 334.0K → 14.96M (in $), with an average increase of 79.0% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -16.94M → -8.11M (in $), with an average increase of 108.9% per quarter
  • BRNS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 95.7%
  • BRNS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 113.6%
  • Price to Sales

    ForBRNS every $1 of sales, investors are willing to pay $2.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Barinthus Biotherapeutics Plc Technicals Summary

Sell

Neutral

Buy

Barinthus Biotherapeutics Plc is currently in a neutral trading position according to technical analysis indicators.

Barinthus Biotherapeutics Plc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Barinthus Biotherapeutics Plc
14.93%
-19.86%
-69.35%
-88.92%
-92.53%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Barinthus Biotherapeutics Plc
NA
NA
NA
-1.57
-0.33
-0.19
NA
4.03
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Barinthus Biotherapeutics Plc
Buy
$44.7M
-92.53%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Barinthus Biotherapeutics Plc

vaccitech is a spin-out company from the university of oxford’s jenner institute, one of the oldest and most renowned vaccine research centres in the world. the company has been formed around two viral vector vaccines, one to prevent influenza and the other to treat prostate cancer. viral vector vaccines are particularly good at treating some of the most recalcitrant illnesses. the underlying technology is built on years of experience perfecting viral vector vaccine technology across multiple indications. the company’s protected chimpanzee adenovirus technology is the best way to generate t-cell responses and thereby generate lasting cell-mediated immunity. the assets are already in the clinic with very promising initial results. the founders of the company are professor adrian hill (director of the jenner institute) and professor sarah gilbert (lead in influenza and mers), who combine their exceptional scientific skills with regulatory and manufacturing experience. this autumn, vaccit
Organization
Barinthus Biotherapeutics Plc
Employees
130
CEO
Mr. William J. Enright MBA
Industry
Miscellaneous

Management People of Barinthus Biotherapeutics Plc

NameTitle
Mr. William J. Enright MBA
CEO & Director
Mr. Graham Griffiths
Chief Operating Officer
Ms. Sarah Gilbert
Co-Founder
Mr. Adrian Hill Ph.D.
Co-Founder & Scientific Advisor
Ms. Gemma Brown
CFO & Company Secretary
Dr. Geoffrey Lynn M.D., Ph.D.
Chief Scientific Officer
Ms. Elizabeth Eagling-Vose M.B.A.
Head of Clinical Operations
Bernie McDonald
Head of IP
Dr. Leon Hooftman M.D.
Chief Medical Officer

Important FAQs about investing in Barinthus Biotherapeutics Plc from India :

What is Barinthus Biotherapeutics Plc share price today?

Barinthus Biotherapeutics Plc share price today stands at $1.11, Open: $1.07 ; Previous Close: $1.16 ; High: $1.17 ; Low: $1.07 ; 52 Week High: $4.16 ; 52 Week Low: $0.80. The stock opens at $1.07, after a previous close of $1.16. The stock reached a daily high of $1.17 and a low of $1.07, with a 52-week high of $4.16 and a 52-week low of $0.80.

Can Indians buy Barinthus Biotherapeutics Plc shares?

Yes, Indians can invest in the Barinthus Biotherapeutics Plc (BRNS) from India.

With INDmoney, you can buy Barinthus Biotherapeutics Plc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Barinthus Biotherapeutics Plc at zero transaction cost.

How can I buy Barinthus Biotherapeutics Plc shares from India?

It is very easy to buy Barinthus Biotherapeutics Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Barinthus Biotherapeutics Plc be purchased?

Yes, you can buy fractional shares of Barinthus Biotherapeutics Plc with INDmoney app.

What are the documents required to start investing in Barinthus Biotherapeutics Plc stocks?

To start investing in Barinthus Biotherapeutics Plc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Barinthus Biotherapeutics Plc

Today’s highest price of Barinthus Biotherapeutics Plc (BRNS) is $1.17.

Today’s lowest price of Barinthus Biotherapeutics Plc (BRNS) is $1.07.

What is today's market capitalisation of Barinthus Biotherapeutics Plc

Today's market capitalisation of Barinthus Biotherapeutics Plc BRNS is 44.7M

What is the 52 Week High and Low Range of Barinthus Biotherapeutics Plc

  • 52 Week High

    $4.16

  • 52 Week Low

    $0.80

What are the historical returns of Barinthus Biotherapeutics Plc?

  • 1 Month Returns

    14.93%

  • 3 Months Returns

    -19.86%

  • 1 Year Returns

    -69.35%

  • 5 Years Returns

    -92.53%

Who is the Chief Executive Officer (CEO) of Barinthus Biotherapeutics Plc

Mr. William J. Enright MBA is the current Chief Executive Officer (CEO) of Barinthus Biotherapeutics Plc.